Amylyx Pharmaceuticals News

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B

Sep 25 18:00 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B

Sep 16 17:42 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer FRATES JAMES M

Sep 16 17:32 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Firestone Karen

Sep 9 16:06 ET

Amylyx Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer FRATES JAMES M

Sep 5 19:58 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILNE GEORGE M JR

Sep 5 19:28 ET

Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%), etc.

Aug 26 18:51 ET

Amylyx Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8 07:19 ET

Amylyx Pharmaceuticals | 8-K: Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 8 07:14 ET

Amylyx Pharmaceuticals | 8-K: Current report

Jul 10 07:09 ET

Amylyx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(3.9%)

Jul 8 16:38 ET

Amylyx Pharmaceuticals | 8-K: Current report

Jun 21 17:11 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FONTEYNE PAUL R.

Jun 7 16:57 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Firestone Karen

Jun 7 16:53 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zeiher Bernhardt G

Jun 7 16:52 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILNE GEORGE M JR

Jun 7 16:49 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Quimi Daphne

Jun 7 16:48 ET

Amylyx Pharmaceuticals | 8-K: Current report

Jun 6 16:12 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Quimi Daphne

May 16 19:42 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mazzariello Gina

May 16 19:42 ET